Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Antiviral treatments for lamivudine‐resistant chronic hepatitis B adult patients

This protocol has been withdrawn

Information

DOI:
https://doi.org/10.1002/14651858.CD008178.pub2Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 04 November 2021see what's new
Type:
  1. Intervention
Stage:
  1. Protocol
Cochrane Editorial Group:
  1. Cochrane Hepato-Biliary Group

Copyright:
  1. Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Shaffer Mok

    Correspondence to: Department of Internal Medicine, Division of Gastroenterology and Liver Diseases, Cooper University Hospital at Rowan University School of Medicine, Mt. Laurel, USA

    [email protected]

  • Vijaya M Musini

    Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada

  • Ken Bassett

    Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada

Sources of support

Internal sources

  • Therapeutic Initiative, Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada

External sources

  • Cochrane Hepato‐Biliary Group, Copenhagen, Denmark

Version history

Published

Title

Stage

Authors

Version

2021 Nov 04

Antiviral treatments for lamivudine‐resistant chronic hepatitis B adult patients

Protocol

Shaffer Mok, Vijaya M Musini, Ken Bassett

https://doi.org/10.1002/14651858.CD008178.pub2

2009 Oct 07

Antiviral treatments for lamivudine‐resistant chronic hepatitis B adult patients

Protocol

Anat Fisher, Vijaya M Musini, Ken Bassett

https://doi.org/10.1002/14651858.CD008178